Search Results - "B cell"

Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies.

Biersteker R; Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. Electronic address: r.biersteker@lumc.nl., Larsen OF; Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Huizinga TWJ; Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Toes REM; Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Hafkenscheid L; Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands; Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. Electronic address: l.hafkenscheid@lumc.nl.

Journal Article; Review , 2025

The challenge of targeting key drivers of CLL and sequencing therapy in an era of experimental therapeutics.

Gordon BK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.

Journal Article; Review , 2025

Single-cell analysis of a bi-clonal chronic lymphocytic leukemia reveals two clones with distinct gene expression pattern.

Dampmann M; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, Germany., Kibler A; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.; Department of Immunodynamics, Institute of Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany., von Tresckow J; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, Germany., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, Germany.; National Center for Tumor Diseases (NCT-West), Campus University Hospital Essen, Germany.; German Cancer Consortium (Partner Site Essen), Germany., Küppers R; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (Partner Site Essen), Germany., Budeus B; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.

Journal Article; Case Reports , 2025

Utility of CCR7 to differentiate classic Hodgkin lymphoma and other B-cell lymphomas by flow cytometry and immunohistochemistry.

Chen X; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, US.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, US., Soma L; Department of Pathology, City of Hope, Duarte, CA, US., Murphy C; Pathology Consultants, PC, Eugene/Springfield Lab, Springfield, OR, US., Tretiakova M; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, US., Naresh KN; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, US.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, US., Fromm JR; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, US.

Journal Article , 2025

Primary thyroid B-cell lymphoma: molecular insights into its clonal evolution and relapse.

Tzioni MM; Department of Pathology, University of Cambridge, Cambridge, UK., Watanabe N; Department of Internal Medicine, Ito Hospital, Tokyo, Japan., Chen Z; Department of Pathology, University of Cambridge, Cambridge, UK., Wu F; Department of Pathology, University of Cambridge, Cambridge, UK., Madej E; Department of Pathology, University of Cambridge, Cambridge, UK., Makker J; Department of Pathology, University of Cambridge, Cambridge, UK., Guo S; Department of Pathology, University of Cambridge, Cambridge, UK., Attygalle AD; Department of Histopathology, Royal Marsden Hospital, London, UK., Wotherspoon A; Department of Histopathology, Royal Marsden Hospital, London, UK., Sugino K; Department of Internal Medicine, Ito Hospital, Tokyo, Japan., Ito K; Department of Internal Medicine, Ito Hospital, Tokyo, Japan., Du MQ; Department of Pathology, University of Cambridge, Cambridge, UK.

Journal Article , 2025

CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy.

Uppin V; Division of Haematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA., Gibbons H; Luminary Therapeutics, Minneapolis, MN, USA., Troje M; Luminary Therapeutics, Minneapolis, MN, USA., Feinberg D; Division of Haematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA., Webber BR; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA., Moriarity BS; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA., Parameswaran R; Division of Haematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA; Pediatric Haematology and Oncology, The Angie Fowler Adolescent & Young Adult Cancer Institute, University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH, USA; The Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: rxp278@case.edu.

Journal Article , 2025

Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.

Belenki D; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Richter-Pechanska P; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Shao Z; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Bhattacharya A; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Lau A; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Nabuco Leva Ferreira de Freitas JA; IMRB, Mondor Institute for Biomedical Research, INSERM U955 - Université Paris Est Créteil, UPEC, Faculté de Médecine de Créteil, Créteil, France., Kandler G; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Hick TP; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany.; Knowledge Management in Bioinformatics, Institute for Computer Science, Humboldt-Universität zu Berlin, Berlin, Germany., Cai X; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Scharnagl E; Johannes Kepler University, Medical Faculty, Linz, Austria., Bittner A; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Schönlein M; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Kase J; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Pardon K; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Brzezicha B; Experimental Pharmacology & Oncology Berlin-Buch GmbH, Berlin, Germany., Thiessen N; Core Unit Bioinformatics - CUBI, Berlin Institute of Health, Berlin, Germany., Bischof O; IMRB, Mondor Institute for Biomedical Research, INSERM U955 - Université Paris Est Créteil, UPEC, Faculté de Médecine de Créteil, Créteil, France., Dörr JR; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany.; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany., Reimann M; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany., Milanovic M; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany.; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Berlin, Germany.; Deutsches Konsortium für Translationale Krebsforschung (German Cancer Consortium), partner site Berlin, Berlin, Germany., Du J; Medical Research Center and Department of Oncology Binzhou Medical University Hospital, 256600, Binzhou, P.R. China., Yu Y; Johannes Kepler University, Medical Faculty, Linz, Austria., Chapuy B; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Berlin, Germany., Lee S; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany.; Johannes Kepler University, Medical Faculty, Linz, Austria., Leser U; Knowledge Management in Bioinformatics, Institute for Computer Science, Humboldt-Universität zu Berlin, Berlin, Germany., Scheidereit C; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Wolf J; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Mathematics and Computer Science, Free University Berlin, Berlin, Germany., Fan DNY; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Deutsches Konsortium für Translationale Krebsforschung (German Cancer Consortium), partner site Berlin, Berlin, Germany., Schmitt CA; Charité - Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Campus Virchow Klinikum, Berlin, Germany. clemens.schmitt@charite.de.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. clemens.schmitt@charite.de.; Johannes Kepler University, Medical Faculty, Linz, Austria. clemens.schmitt@charite.de.; Deutsches Konsortium für Translationale Krebsforschung (German Cancer Consortium), partner site Berlin, Berlin, Germany. clemens.schmitt@charite.de.; Kepler University Hospital, Department of Hematology and Oncology, Krankenhausstraße 9, 4020, Linz, Austria. clemens.schmitt@charite.de.

Journal Article , 2025

Histomorphologic spectrum of nodal marginal zone lymphoma as defined by its methylome.

Spada F; Institute of Pathology, Ulm University, Ulm, Germany., Rosenwald A; Institute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany., Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany., Feller AC; Department of Pathology, University Hospital of Schleswig-Holstein, Lübeck, Germany., Fend F; Institute of Pathology and Neuropathology and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany., Fürstberger A; Institute of Pathology, Ulm University, Ulm, Germany., Barth TFE; Institute of Pathology, Ulm University, Ulm, Germany., Möller P; Institute of Pathology, Ulm University, Ulm, Germany.

Journal Article , 2025

Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACE.

Camus V; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France., Viennot M; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France., Viailly PJ; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France., Drieux F; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.; Department of Pathology, Centre Henri Becquerel, Rouen, France., Veresezan EL; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.; Department of Pathology, Centre Henri Becquerel, Rouen, France., Bobée V; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.; Biological Hematology Laboratory, Centre Hospitalier Universitaire de Rouen, Hôpital Charles Nicolle, Rouen, France., Rainville V; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France., Bohers E; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France., Sesques P; Department of Hematology, Hospices Civils de Lyon, Pierre-Bénite, France., Haioun C; Department of Lymphoid Malignancies, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France., Durot E; Department of Hematology, Centre Hospitalier Universitaire de Reims, Reims, France., Bayaram M; Department of Pathology, Centre Hospitalier Universitaire de Reims, Reims, France., Rossi C; Department of Hematology, Centre Hospitalier Universitaire de Dijon, Dijon, France., Martin L; Department of Pathology, Centre Hospitalier Universitaire de Dijon, Dijon, France., Penther D; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.; Laboratory of Genetic Oncology, Centre Henri Becquerel, Rouen, France., Kaltenbach S; Centre Hospitalier Universitaire Necker, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Paris, France., Bruneau J; University of Paris, Institut Imagine, Institut des Maladies Génétiques, INSERM UMR1163, Paris, France.; Department of Pathology, Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpitaux Necker et Robert Debré, Paris, France., Paillassa J; Department of Hematology, Centre Hospitalier Universitaire d'Angers, Angers, France., Tournilhac O; Department of Hematology, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France., Gower N; Department of Hematology, Centre Hospitalier Universitaire de Lille, Hôpital Claude Hurriez, Lille, France., Willaume A; Department of Hematology, Hôpital Saint Vincent de Paul, Groupe Hospitalier de l'Institut Catholique de Lille, Lille, France., Antier C; Department of Hematology, Centre Hospitalier Universitaire de Nantes, Nantes, France., Renaud L; Department of Hematology, Gustave Roussy, Villejuif, France., Lévêque E; Clinical Research Unit, Centre Henri Becquerel, Rouen, France., Decazes P; Department of Nuclear Medicine and QuantIF-LITIS-EA4108, Centre Henri Becquerel, University of Rouen, Rouen, France., Becker S; Department of Pathology, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France., Tonnelet D; Department of Nuclear Medicine and QuantIF-LITIS-EA4108, Centre Henri Becquerel, University of Rouen, Rouen, France., Gaulard P; Department of Pathology, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France., Tilly H; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France., Molina TJ; University of Paris, Institut Imagine, Institut des Maladies Génétiques, INSERM UMR1163, Paris, France.; Department of Pathology, Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpitaux Necker et Robert Debré, Paris, France., Traverse-Glehen A; Department of Pathology, Hospices Civils de Lyon, Université Lyon 1, Pierre-Bénite, France., Donzel M; Department of Pathology, Hospices Civils de Lyon, Université Lyon 1, Pierre-Bénite, France., Ruminy P; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France., Jardin F; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Journal Article , 2025

High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.

Lone W; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Bouska A; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Herek TA; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Amador C; Department of Pathology, University of Miami, Miami, Florida, USA., Song J; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA., Xu AM; Cedars-Sinai Medical Center and Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA., Jochum D; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Issa II; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Weisenburger DD; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Zhang X; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Bhagavathi SK; Department of Pathology, University of Iowa, Iowa City, Iowa, USA., Heavican-Foral TB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Sharma S; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Shah AR; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Mir AR; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Alkhinji AA; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., El-Gamal D; Eppley Institute for Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA., Dave BJ; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Human Genetics Laboratory, University of Nebraska Medical Center, Omaha, Nebraska, USA., Hartert K; Department of Biological Sciences, Minnesota State University, Mankato, Minnesota, USA., Yu J; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Saumyaranjan M; All India Institute of Medical Sciences, New Delhi, India., Greiner TC; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Vose J; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., McKeithan TW; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA., Fu K; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Green M; Department of Lymphoma/Myeloma and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bi C; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Merchant A; Cedars-Sinai Medical Center and Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA., Chan WC; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA., Iqbal J; Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Journal Article , 2025

Understanding splenic B-cell lymphoma/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions.

Naresh KN; Section of Pathology, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

Journal Article; Review , 2024

Current status of BAFF targeting immunotherapy in B-cell neoplasm.

Tagami N; Laboratory of Molecular Immunology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan., Yuda J; Department of Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan., Goto Y; Laboratory of Molecular Immunology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan. aygoto@g.ecc.u-tokyo.ac.jp.

Journal Article; Review , 2024

Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice.

Stohl W; Division of Rheumatology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA., Wu Y; Division of Rheumatology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA., Stohl M; New York State Psychiatric Institute, New York, New York, USA.

Journal Article; Research Support, Non-U.S. Gov't , 2024

Clinicopathological characteristics and genomic profiling in patients with transformed lymphoma: a monocentric retrospective study.

Zhao X; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Bian H; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Hao F; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Shao S; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Wu C; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Zhang Q; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Wu M; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Li Z; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Gao C; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China.

Journal Article , 2024

Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.

Charalampopoulou S; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Chapiro E; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zürich, Zurich, Switzerland., Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain., Martínez-Farran A; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Aymerich M; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain., Rozman M; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain., Roos-Weil D; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France., Bernard O; Gustave Roussy, INSERN U1170, Villejuif, France., Susin SA; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France., Parker H; Cancer Genomics, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Walewska R; Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom., Oakes CC; Division of Hematology, The Ohio State University, Columbus, OH., Strefford JC; Cancer Genomics, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain., Matutes E; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain., Duran-Ferrer M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Nguyen-Khac F; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France., Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.

Journal Article , 2024

NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter's Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics.

Rohan P; Stem Cell Laboratory, Specialized Laboratories Division, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil., Binato R; Stem Cell Laboratory, Specialized Laboratories Division, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil., Abdelhay E; Stem Cell Laboratory, Specialized Laboratories Division, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.

Journal Article , 2024

Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in <I>de novo</I> large B-cell lymphoma and transformed low-grade B-cell lymphoma.

Benjamini O; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv. ohad.benjamini@sheba.health.gov.il., Fried S; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shouval R; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Flynn JR; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York., Beyar-Katz O; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa., Leslie LA; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey., Zucherman T; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa., Yerushalmi R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shem-Tov N; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Palomba ML; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Danylesko I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Sdayoor I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Malka H; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa., Itzhaki O; Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Hashomer., Suh H; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey., Devlin SM; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York., Marcus R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Dahi PB; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Jacoby E; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv, Israel; Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Chaim Sheba Medical Center, Hashomer., Shah GL; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York., Sauter CS; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Ip A; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey, United States; Hackensack Meridian School of Medicine, Nutley, NJ., Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shimoni A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Scordo M; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv.

Journal Article; Multicenter Study , 2024

Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms.

Wu S; Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China., Luo Q; Iaso Biotherapeutics Co. Ltd., Nanjing, Jiangsu, China., Li F; Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China., Zhang S; Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China., Zhang C; Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Liu J; Iaso Biotherapeutics Co. Ltd., Nanjing, Jiangsu, China., Shao B; Iaso Biotherapeutics Co. Ltd., Nanjing, Jiangsu, China., Hong Y; Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Tan T; Iaso Biotherapeutics Co. Ltd., Nanjing, Jiangsu, China., Dong X; Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.; Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Chen B; Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.; Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Journal Article , 2024

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial.

Tedeschi A; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy. Electronic address: alessandra.tedeschi@ospedaleniguarda.it., Frustaci AM; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy., Condoluci A; Department of Oncology, Institute of Oncology Research, Bellinzona, Switzerland; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Coscia M; Department of Oncology ASST Sette Laghi, Ospedale di Circolo, Varese, Italy., Chiarle R; Division of Hematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Zinzani PL; Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'L e A Seràgnoli', Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Motta M; SC Ematologia, ASST Spedali Civili, Brescia, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Quaresmini G; Azienda Socio-Sanitaria Territoriale Papa Giovanni XXVIII, Bergamo, Italy., Scarfò L; Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy., Catania G; Division of Hematology, Azienda Ospedaliera SS Arrigo e Biagio e Cesare Arrigo, Alessandria, Italy., Deodato M; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy., Jones R; University Division of Hematology, AOU Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Tabanelli V; Division of Hematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy., Griggio V; University Division of Hematology, AOU Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Stüssi G; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biomedical Science, Universita' della Svizzera Italiana, Lugano, Switzerland., Calleri A; Division of Hematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy., Pini K; Department of Oncology, Institute of Oncology Research, Bellinzona, Switzerland., Cairoli R; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy., Zenz T; Department of Medical Oncology & Hematology, University Hospital and University of Zürich, Zürich, Switzerland; The LOOP Zürich-Medical Research Center, Zürich, Switzerland., Signori A; Department of Health Science, University of Genoa, Genoa, Italy., Zucca E; Department of Oncology, Institute of Oncology Research, Bellinzona, Switzerland; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biomedical Science, Universita' della Svizzera Italiana, Lugano, Switzerland., Rossi D; Department of Oncology, Institute of Oncology Research, Bellinzona, Switzerland; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biomedical Science, Universita' della Svizzera Italiana, Lugano, Switzerland., Montillo M; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy.

Journal Article; Clinical Trial, Phase II; Multicenter Study , 2024

Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO.

Bailén R; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain., Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Delgado J; Department of Haematology, Hospital Universitario Virgen del Rocío, Institute of Biomedicine of Seville (IBiS/CSIC/CIBERONC), University of Seville, Seville, Spain., López-Corral L; Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain., Hernani-Morales R; Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain., Ortiz-Maldonado V; Department of Haematology, Hospital Clínic, Barcelona, Spain., Guerreiro M; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Caballero AC; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Guerra-Domínguez ML; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Sánchez-Pina JM; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Peña M; Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, IDIBELL, Barcelona, Spain., Torrent A; Department of Hematology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Pérez-Martínez A; Department of Paediatric Hemato-Oncology, Hospital Universitario La Paz, Madrid, Spain., Bastos-Oreiro M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.; Universidad Complutense de Madrid, Spain., Reguera-Ortega JL; Department of Haematology, Hospital Universitario Virgen del Rocío, Institute of Biomedicine of Seville (IBiS/CSIC/CIBERONC), University of Seville, Seville, Spain., Martín A; Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain., Hernandez-Boluda JC; Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain., Martínez-Cibrián N; Department of Haematology, Hospital Clínic, Barcelona, Spain., Sanz J; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Briones J; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Henriquez HL; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Calbacho M; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Mussetti A; Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, IDIBELL, Barcelona, Spain., Sancho JM; Department of Hematology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Barba P; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Kwon M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.; Universidad Complutense de Madrid, Spain.. Electronic address: mi.kwon@salud.madrid.org.

GETH-TC (Spanish Group of Stem Cell Transplantation and Cell Therapy) and GELTAMO (Spanish Group of Lymphoma and Autologous Stem Cell Transplantation)

Journal Article; Multicenter Study , 2024